Retraction of: Scientific Reports https://doi.org/10.1038/srep42021, published online 10 February 2017
The Editors have retracted this Article.
After publication of this Article it was brought to the Editors’ attention that some of the data appear to overlap with data in other articles from the same author group, where the data is partially attributed to different samples. Specifically:
-
In Figure 3B the “vehicle + 50% HA” group appears to overlap with data in Figure 8 published in1;
-
In Figure 3B the “oxaliplatin + 50% HA” group appears to overlap with data in Figure 4a published in2;
-
In Figure 3C the “vehicle + 50% HA” group appears to overlap with data in Figure 4 published in3;
-
In Figure 4A the “vehicle + 50% HA” group appears to overlap with data in Figure 7d “vehicle + vehicle cg1” group published in2;
-
In Figure 4A the “vehicle + vehicle” group appears to overlap with data in Figure 7d “vehicle + vehicle M1” group published in2.
The Editors reached out to the Authors to request raw data. The Authors were unable to provide the data and the concerns remain unresolved. The Editors therefore no longer have confidence in the results presented in this Article.
All Authors agree with the retraction of the Article.
References
Di Cesare, M. L., Pacini, A., Micheli, L., Zanardelli, M. & Ghelardini, L. Glial role in oxaliplatin-induced neuropathic pain. Exp. Neurol. https://doi.org/10.1016/j.expneurol.2014.06.016 (2014).
Pacini, A. et al. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. Exp. Neurol. https://doi.org/10.1016/j.expneurol.2016.04.022 (2016).
Di Cesare, M. L. et al. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J. Pain. https://doi.org/10.1016/j.jpain.2013.08.002 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Di Cesare Mannelli, L., Pacini, A., Micheli, L. et al. Retraction Note: Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?. Sci Rep 13, 9979 (2023). https://doi.org/10.1038/s41598-023-37011-5
Published:
DOI: https://doi.org/10.1038/s41598-023-37011-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
